The Centre for Aging + Brain Health Innovation (CABHI), led by Baycrest, today announced support for the development and validation testing of 31 new innovations in aging and brain health care – driving forward opportunities for promising Canadian products and services aimed at improving the quality of life for those affected by dementia and their caregivers.
A total of $1.4 M in support has been leveraged through CABHI’s Spark program, which aims at fostering innovations from point-of-care workers who have grassroots ideas they want to develop into real-world applications for the aging population.
Among the funded projects:
- Development of a new behavioural and psychological symptoms of dementia (BPSD) app that aims to help providers understand, assess and manage individuals with BSPD utilizing accessible best practice evidence
- Virtual wound care for clients living in residential care, which connects caregivers with highly skilled wound care clinicians who can make an assessment in real time. Caregivers can then immediately implement the treatment plan advised by the wound care clinician – reducing the risk of infection or having the wound worsen any further.
- Improving opioid and medication use for aging adults by developing and testing a process for clinicians to work together to identify and target high-risk co-prescribed medication combinations in older adults in primary care
“Through CABHI’s programs and services, innovators are emboldened to advance their projects through a changing global landscape – to make the most impact across the healthcare sector in Ontario, Canada and across the world,” said Dr. William Reichman, Baycrest’s President and CEO. “We look forward to seeing the many ways innovations in our pipeline will make a real difference in the lives of older adults impacted by dementia as well as their caregivers.”